Stifel Financial’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-112,853
| Closed | -$83.3K | – | 3495 |
|
|
2024
Q4 | $83.3K | Buy |
112,853
+60,856
| +117% | +$73.4K | ﹤0.01% | 3270 |
|
|
2024
Q3 | $81.6K | Buy |
51,997
+546
| +1% | +$972 | ﹤0.01% | 3268 |
|
|
2024
Q2 | $86.4K | Sell |
51,451
-723
| -1% | -$1.3K | ﹤0.01% | 3233 |
|
|
2024
Q1 | $125K | Buy |
52,174
+12,522
| +32% | +$26.9K | ﹤0.01% | 3169 |
|
|
2023
Q4 | $60.7K | Sell |
39,652
-42,315
| -52% | -$50.3K | ﹤0.01% | 3213 |
|
|
2023
Q3 | $89.3K | Sell |
81,967
-46,952
| -36% | -$82.4K | ﹤0.01% | 3125 |
|
|
2023
Q2 | $295K | Buy |
128,919
+608
| +0.5% | +$1.61K | ﹤0.01% | 2833 |
|
|
2023
Q1 | $312K | Buy |
128,311
+3,827
| +3% | +$8.77K | ﹤0.01% | 2788 |
|
|
2022
Q4 | $238K | Sell |
124,484
-12,199
| -9% | -$26K | ﹤0.01% | 2894 |
|
|
2022
Q3 | $328K | Sell |
136,683
-2,694
| -2% | -$7.46K | ﹤0.01% | 2674 |
|
|
2022
Q2 | $259K | Buy |
139,377
+6,328
| +5% | +$12.1K | ﹤0.01% | 2826 |
|
|
2022
Q1 | $278K | Buy |
133,049
+27,630
| +26% | +$76.6K | ﹤0.01% | 2923 |
|
|
2021
Q4 | $415K | Sell |
105,419
-10,495
| -9% | -$51K | ﹤0.01% | 2706 |
|
|
2021
Q3 | $558K | Buy |
115,914
+34,325
| +42% | +$141K | ﹤0.01% | 2518 |
|
|
2021
Q2 | $374K | Buy |
81,589
+3,671
| +5% | +$17.7K | ﹤0.01% | 2750 |
|
|
2021
Q1 | $457K | Buy |
77,918
+7,689
| +11% | +$53.2K | ﹤0.01% | 2545 |
|
|
2020
Q4 | $240K | Buy |
70,229
+1,369
| +2% | +$2.61K | ﹤0.01% | 2722 |
|
|
2020
Q3 | $99K | Buy |
68,860
+3,781
| +6% | +$6.73K | ﹤0.01% | 2755 |
|
|
2020
Q2 | $130K | Sell |
65,079
-262
| -0.4% | -$513 | ﹤0.01% | 2679 |
|
|
2020
Q1 | $126K | Sell |
65,341
-6,794
| -9% | -$20.2K | ﹤0.01% | 2549 |
|
|
2019
Q4 | $298K | Sell |
72,135
-1,904
| -3% | -$7.33K | ﹤0.01% | 2536 |
|
|
2019
Q3 | $227K | Sell |
74,039
-170
| -0.2% | -$526 | ﹤0.01% | 2591 |
|
|
2019
Q2 | $473K | Sell |
74,209
-24,578
| -25% | -$147K | ﹤0.01% | 2245 |
|
|
2019
Q1 | $556K | Sell |
98,787
-7,558
| -7% | -$45.9K | ﹤0.01% | 2006 |
|
|
2018
Q4 | $705K | Sell |
106,345
-38,349
| -27% | -$311K | ﹤0.01% | 1754 |
|
|
2018
Q3 | $1.53M | Buy |
144,694
+15,430
| +12% | +$177K | ﹤0.01% | 1419 |
|
|
2018
Q2 | $1.55M | Buy |
129,264
+24,608
| +24% | +$252K | ﹤0.01% | 1353 |
|
|
2018
Q1 | $902K | Buy |
104,656
+14,378
| +16% | +$133K | ﹤0.01% | 1641 |
|
|
2017
Q4 | $893K | Buy |
90,278
+9,859
| +12% | +$102K | ﹤0.01% | 1584 |
|
|
2017
Q3 | $987K | Buy |
80,419
+8,833
| +12% | +$130K | ﹤0.01% | 1486 |
|
|
2017
Q2 | $1.18M | Sell |
71,586
-5,835
| -8% | -$90.4K | ﹤0.01% | 1393 |
|
|
2017
Q1 | $1.11M | Buy |
77,421
+4,134
| +6% | +$61.3K | ﹤0.01% | 1402 |
|
|
2016
Q4 | $1.01M | Buy |
73,287
+3,497
| +5% | +$56.1K | ﹤0.01% | 1392 |
|
|
2016
Q3 | $1.26M | Buy |
69,790
+7,801
| +13% | +$126K | 0.01% | 1211 |
|
|
2016
Q2 | $890K | Buy |
+61,989
| New | +$841K | ﹤0.01% | 1409 |
|
|
2016
Q1 | – | Sell |
-66,971
| Closed | -$892K | – | 2328 |
|
|
2015
Q4 | $892K | Sell |
66,971
-1,507
| -2% | -$18.5K | ﹤0.01% | 1355 |
|
|
2015
Q3 | $735K | Buy |
68,478
+6,182
| +10% | +$67.5K | ﹤0.01% | 1350 |
|
|
2015
Q2 | $501K | Buy |
62,296
+21,500
| +53% | +$158K | ﹤0.01% | 1687 |
|
|
2015
Q1 | $270K | Sell |
40,796
-1,543
| -4% | -$10.5K | ﹤0.01% | 1959 |
|
|
2014
Q4 | $270K | Buy |
42,339
+1,969
| +5% | +$15.9K | ﹤0.01% | 1930 |
|
|
2014
Q3 | $398K | Sell |
40,370
-15,367
| -28% | -$164K | ﹤0.01% | 1659 |
|
|
2014
Q2 | $628K | Sell |
55,737
-6,900
| -11% | -$74.1K | 0.01% | 1361 |
|
|
2014
Q1 | $759K | Buy |
+62,637
| New | +$800K | 0.01% | 1203 |
|
Other funds holding LXRX
AG
SL
SSA
